Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy

J Dermatol. 2017 Apr;44(4):e70. doi: 10.1111/1346-8138.13571. Epub 2016 Sep 8.

Authors

Atsushi Narahira¹, Teruki Yanagi¹, Kyu Yong Cho², Akinobu Nakamura², Hideaki Miyoshi², Hiroo Hata¹, Keisuke Imafuku¹, Shinya Kitamura¹, Hiroshi Shimizu¹

Affiliations

¹ Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
² Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

PMID: 27608187
DOI: 10.1111/1346-8138.13571

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenocorticotropic Hormone / deficiency*
Aged
Antineoplastic Agents, Immunological / adverse effects*
Diagnosis, Differential
Endocrine System Diseases / chemically induced*
Endocrine System Diseases / diagnosis
Female
Genetic Diseases, Inborn / chemically induced*
Genetic Diseases, Inborn / diagnosis
Humans
Hypoglycemia / chemically induced*
Hypoglycemia / diagnosis
Melanoma / drug therapy
Nivolumab / adverse effects*

Substances

Antineoplastic Agents, Immunological
Nivolumab
Adrenocorticotropic Hormone

Supplementary concepts

ACTH Deficiency, Isolated